1.
The sponsor shall notify each Member State concerned of the end of a clinical trial in relation to that Member State through the EU portal. That notification shall be made within 15 days from the end of the clinical trial in relation to that Member State.
← Article 37 · All articles · art_37__para_1__text_1 →
Source: EUR-Lex (Cellar) · retrieved 2026-11-06 · Text as adopted (Official Journal); later amendments are not incorporated in this text.